EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ 4 carriers

Melanie Quiring iD, Arunima Kapoor, John Paul M Alitin, Basant Lashin, Jillian L Joyce, Allison C Engstrom, Trevor Lohman, Aimée Gaubert, Fatemah Shenasa, Kevin W Law, Farrah Ferrer, Danny J J Wang und 5 weitere

Alzheimer's & Dementia · 2026-10 · 22 (10)

DOI: 10.1002/alz.71934 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 21.10.2026. Verfasst von Melanie Quiring und 16 weiteren Autor:innen. Beteiligte Einrichtung: Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Apolipoprotein E4, Cerebrovascular Circulation, Temporal Lobe, Cognition. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NIA NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION It remains unclear whether medial temporal lobe (MTL) hyperperfusion in cognitively unimpaired apolipoprotein E ( APOE) ɛ4 carriers reflects resilience or dysfunction. We examined whether cortical MTL cerebral blood flow (CBF) relates to cognition differently in APOE ɛ4 carriers and noncarriers with and without AD pathophysiological changes. METHODS One hundred forty‐eight cognitively unimpaired older adults underwent pseudo‐continuous arterial spin labeling MRI to quantify MTL CBF and assessment of memory and executive function. In a subset ( n = 126), AD pathology was indexed using plasma phosphorylated tau 217 (pTau 217 ). RESULTS APOE ɛ4 carriers showed higher MTL CBF than noncarriers. Higher MTL CBF was associated with better executive function only in pTau 217 ‐negative APOE ɛ4 carriers. Interactions remained significant after adjusting for MTL cortical volume or white matter hyperintensities. DISCUSSION Hyperperfusion in cognitively unimpaired APOE ɛ4 carriers may reflect a resilience biomarker related to better cognitive function in the absence of detectable AD pathophysiological changes. Highlights Apolipoprotein E ( APOE) ɛ4 carriers show elevated medial temporal lobe (MTL) cerebral blood flow (CBF). Higher MTL CBF is linked to better executive function in APOE ɛ4 carriers. This association is only observed in APOE ɛ4 carriers who are pTau 217 ‐negative. MTL hyperperfusion may mark resilience in APOE ɛ4 carriers at risk for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein E4Cerebrovascular CirculationTemporal LobeCognitionHumansFemaleAgedMagnetic Resonance ImagingMaleBiomarkersExecutive FunctionHeterozygotetau ProteinsNeuropsychological TestsAlzheimer Disease

Stichwörter der Autor:innen

APOEcerebral blood flowcognitive resilienceexecutive functionhyperperfusionplasma p‐tau217preclinical Alzheimer's disease

Substanzen

Apolipoprotein E4Biomarkerstau Proteins

Autor:innen und Institutionen

  • Leonard Davis School of Gerontology, University of Southern California, Los Angeles, California, USA.
  • Department of Psychological Science, University of California, Irvine, California, USA.
  • Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Stevens Neuroimaging and Informatics Institute, University of Southern California, Los Angeles, California, USA.
  • Department of Pathology and Laboratory Medicine, University of California, Irvine, Medical Sciences D, Irvine, California, USA.
  • Department of Neurology, University of California, Irvine, Irvine, California, USA.

ORCID-Profile: Melanie Quiring, Daniel A Nation

Förderung

  • NIH HHS
  • NIA NIH HHS
  • American Heart Association
  • National Institutes of Health
  • National Institute on Aging

Zitieren

APA

Quiring, M., Kapoor, A., Alitin, J. P. M., Lashin, B., Joyce, J. L., Engstrom, A. C., Lohman, T., Gaubert, A., Shenasa, F., Law, K. W., Ferrer, F., Wang, D. J. J., Head, E., Malhas, R., Rodgers, K., Han, S. D., & Nation, D. A. (2026). Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ 4 carriers. Alzheimer's & Dementia, 22(10). https://doi.org/10.1002/alz.71934

Vancouver

Quiring M, Kapoor A, Alitin JPM, Lashin B, Joyce JL, Engstrom AC, et al. Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ 4 carriers. Alzheimer's & Dementia. 2026;22(10). doi:10.1002/alz.71934

BibTeX
@article{Quiring2026,
  author = {Quiring, Melanie and Kapoor, Arunima and Alitin, John Paul M and Lashin, Basant and Joyce, Jillian L and Engstrom, Allison C and Lohman, Trevor and Gaubert, Aimée and Shenasa, Fatemah and Law, Kevin W and Ferrer, Farrah and Wang, Danny J J and Head, Elizabeth and Malhas, Rond and Rodgers, Kathleen and Han, S Duke and Nation, Daniel A},
  title = {Cerebral blood flow as a biomarker of resilience in cognitively unimpaired APOE ɛ 4 carriers},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  volume = {22},
  number = {10},
  doi = {10.1002/alz.71934}
}
Kostenlos starten →